Real-time enrollment status for this hematologic malignancies clinical trial
Current Status
Suspended
Checked: April 17, 2026 at 3:43 AM UTC
| NCT Number | NCT05322850 |
| Recruiting Status | Suspended |
| Condition | Hematologic Malignancies |
| Phase | Clinical Trial |
| Target Enrollment | 40 participants |
| Active Locations | 4 sites in the US |
| Sponsor | University of Florida |
| Last Updated on CT.gov | April 13, 2026 (4 days ago) |
As of April 17, 2026: Clinical trial NCT05322850 is currently suspended participants. This clinical trial study for hematologic malignancies is not currently accepting new participants at 4 locations across the United States. The study is sponsored by University of Florida. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05322850 is currently suspended. The study may resume recruiting in the future.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05322850 was last updated 4 days ago (April 13, 2026). HelloStudys verifies this status automatically.